Evidence map›Paper›PMID 29172684›Full record

ArticleThe British journal of radiology2018

Faster and safer? FLASH ultra-high dose rate in radiotherapy.

Marco Durante, Elke Bräuer-Krisch, Mark Hill

Open access · greenAbstract read
In one paragraph

Article in The British journal of radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 2 syntheses or guidelines pooled it, 217 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. A Feasibility Study of Preclinical Ocular X-Ray FLASH Radiation Therapy.International journal of radiation oncology, biology, physics · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Democratizing FLASH Radiotherapy.Seminars in radiation oncology · 2024
    Review
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Marco Durante1 National laboratories, Trento Institute for Fundamental Physics and Applications (TIFPA), National Institute of Nuclear Physics (INFN), University of Trento , Trento Institute for Fundamental Physics and Applications (TIFPA), National Institute of Nuclear Physics (INFN), University of Trento , Trento , Italy.ORCID http://orcid/0000-0002-4615-553X
Elke Bräuer-Krisch2 National laboratories, ESRF-The European Synchrotron , ESRF-The European Synchrotron , Grenoble , France.
Mark Hill3 Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, Gray Laboratories, University of Oxford , CRUK/MRC Oxford Institute for Radiation Oncology, Gray Laboratories, University of Oxford , Oxford , UK.
European Synchrotron Radiation Facility · FRUniversity of Oxford · GBUniversity of Trento · IT

Funding

Medical Research Council MC_U142760473
6 · The paper itself

Abstract

Recent results from the Franco-Swiss team of Institute Curie and Centre Hospitalier Universitaire Vaudois demonstrate a remarkable sparing of normal tissue after irradiation at ultra-high dose rate (>40 Gy s

Indexed as

Radiotherapy DosageAnimalsHumansNeoplasmsOrgans at RiskRadiation Injuries

Identifiers

PMID29172684
PMCPMC5965780
OpenAlexW2769131763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.